|
ALK–ATIC
(HGNC:427, HGNC:794)
|
MONDO:0006112
(MONDO:0006112)
|
strong |
strong |
moderate |
strong |
weak |
|
|
ALK–NPM1
(HGNC:427, HGNC:7910)
|
MONDO:0009348
(MONDO:0009348)
|
strong |
strong |
moderate |
strong |
weak |
|
|
EWSR1–SMAD3
(HGNC:3508, HGNC:6769)
|
spindle cell neoplasm
(MONDO_0020664)
|
strong |
weak |
moderate |
strong |
weak |
|
|
EWSR1–FLII
(HGNC:3508, HGNC:3750)
|
MONDO:0012817
(MONDO:0012817)
|
weak |
weak |
weak |
weak |
weak |
|
|
ALK–MSN
(HGNC:427, HGNC:7373)
|
MONDO:0020325
(MONDO:0020325)
|
moderate |
moderate |
weak |
strong |
weak |
|
|
ETV6–MN1
(HGNC:3495, HGNC:7180)
|
acute lymphoblastic leukemia
(MONDO_0004967)
|
strong |
strong |
strong |
moderate |
weak |
|
|
SERPINE1–FOSB
(HGNC:8583, HGNC:3797)
|
MONDO:0004187
(MONDO:0004187)
|
strong |
strong |
moderate |
strong |
weak |
|
|
FOXO1–PAX7
(HGNC:3819, HGNC:8621)
|
alveolar rhabdomyosarcoma
(MONDO_0009994)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
ALK–KLC1
(HGNC:427, HGNC:6387)
|
MONDO:1040026
(MONDO:1040026)
|
strong |
strong |
moderate |
moderate |
strong |
|
|
GAB1–ABL1
(HGNC:4066, HGNC:76)
|
soft tissue neoplasm
(MONDO_0006424)
|
moderate |
weak |
weak |
moderate |
weak |
|
|
FOXO1–PAX3
(HGNC:3819, HGNC:8617)
|
MONDO:0009994
(MONDO:0009994)
|
strong |
moderate |
strong |
strong |
moderate |
|
|
FN1–ALK
(HGNC:3778, HGNC:427)
|
MONDO:0024621
(MONDO:0024621)
|
strong |
strong |
moderate |
moderate |
weak |
|
|
GATA6–FOXO1
(HGNC:4174, HGNC:3819)
|
MONDO:0021169
(MONDO:0021169)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
FOXP1–IGH
(HGNC:3823, HGNC:5477)
|
MONDO:0018905
(MONDO:0018905)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
FOXO3–KMT2A
(HGNC:3821, HGNC:7132)
|
therapy related acute myeloid leukemia and myelodysplastic syndrome
(MONDO_0019457)
|
strong |
weak |
moderate |
moderate |
weak |
|
|
FLT3–PML
(HGNC:3765, HGNC:9113)
|
MONDO:0012883
(MONDO:0012883)
|
weak |
weak |
weak |
weak |
weak |
|
|
FN1–KMT2A
(HGNC:3778, HGNC:7132)
|
MONDO:0010643
(MONDO:0010643)
|
weak |
weak |
weak |
weak |
weak |
|
|
FOS–FOSB
(HGNC:3796, HGNC:3797)
|
epithelioid hemangioma
(MONDO_0021169)
|
strong |
weak |
moderate |
strong |
weak |
|
|
FGFR2–NRG1
(HGNC:3689, HGNC:7997)
|
MONDO:0019087
(MONDO:0019087)
|
strong |
strong |
moderate |
strong |
weak |
|
|
FGFR2–FGFR3
(HGNC:3689, HGNC:3690)
|
MONDO:0002108
(MONDO:0002108)
|
weak |
weak |
weak |
weak |
weak |
|